BlueAllele is dedicated to enhancing gene editing technologies for the treatment of genetic diseases. By advancing precision and quality in biotechnology and pharmaceuticals, the company aims to revolutionize therapies, providing innovative solutions in the life sciences sector to improve patient outcomes.
Specialties
Gene Editing Systems
Gene Correction Technologies
Advanced Repair Templates
Innovative Therapeutic Solutions
Precision Biotechnology
Products & Services
Gene Editing Technologies
Gene Correction Methods
Repair Template Technologies
Biotechnology Solutions
Pharmaceutical Innovations
Contact Information
No contact information available
Competitors & Similar Companies(10)
CRISPR Therapeutics
Massachusetts, • United States
Editas Medicine
Massachusetts, • United States
Intellia Therapeutics
Massachusetts, • United States
Vertex Pharmaceuticals
Massachusetts, • United States
Regeneron Pharmaceuticals
New York, • United States
Amgen
California, • United States
Sangamo Therapeutics
British Columbia, • Canada
Beam Therapeutics
Massachusetts, • United States
Novartis
Basel-City, • Switzerland
Gilead Sciences
California, • United States
News & Media
Search Terms:
blueallele
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about BlueAllele
Where is BlueAllele located?
The headquarter of BlueAllele is located in Oakdale, Minnesota, United States
BlueAllele is dedicated to enhancing gene editing technologies for the treatment of genetic diseases. By advancing precision and quality in biotechnology and pharmaceuticals, the company aims to revolutionize therapies, providing innovative solutions in the life sciences sector to improve patient outcomes.